Angiotensin-(1-7) treatment improves pneumonia and prevents sepsis caused by pneumococcal infection

Steel HC, Cockeran R, Anderson R, Feldman C. Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm. 2013;2013:490346.

PubMed  PubMed Central  Google Scholar 

Ahn D, Wickersham M, Riquelme S, Prince A. The effects of IFN-lambda on epithelial barrier function contribute to Klebsiella pneumoniae ST258 pneumonia. Am J Respir Cell Mol Biol. 2019;60:158–66.

PubMed  PubMed Central  Google Scholar 

Welte T. Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality. Eur J Clin Microbiol Infect Dis. 2012;31:33–47.

PubMed  Google Scholar 

File TM Jr, Ramirez JA. Community-acquired pneumonia. N Engl J Med. 2023;389:632–41.

PubMed  Google Scholar 

Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004;143:269–83.

PubMed  Google Scholar 

Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4:21.

PubMed  PubMed Central  Google Scholar 

Luck JN, Tettelin H, Orihuela CJ. Sugar-coated killer: serotype 3 pneumococcal disease. Front Cell Infect Microbiol. 2020;10:613287.

PubMed  PubMed Central  Google Scholar 

Choi EH, Zhang F, Lu YJ, Malley R. Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies. Clin Vaccine Immunol. 2016;23:162–7.

PubMed  PubMed Central  Google Scholar 

Narciso AR, Dookie R, Nannapaneni P, Normark S, Henriques-Normark B. Streptococcus pneumoniae epidemiology, pathogenesis and control. Nat Rev Microbiol. 2025;23:256–71.

PubMed  Google Scholar 

Dockrell DH, Whyte MKB, Mitchell TJ. Pneumococcal pneumonia: mechanisms of infection and resolution. Chest. 2012;142:482–91.

PubMed  PubMed Central  Google Scholar 

Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: invasion and inflammation. Microbiol Spectr. 2019. https://doi.org/10.1128/microbiolspec.GPP3-0004-2018.

Article  PubMed  PubMed Central  Google Scholar 

Levy BD, Serhan CN. Resolution of acute inflammation in the lung. Annu Rev Physiol. 2014;76:467–92.

PubMed  Google Scholar 

Sugimoto MA, Vago JP, Perretti M, Teixeira MM. Mediators of the resolution of the inflammatory response. Trends Immunol. 2019;40:212–27.

PubMed  Google Scholar 

Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273–88.

PubMed  PubMed Central  Google Scholar 

Costa VV, Resende F, Melo EM, Teixeira MM. Resolution pharmacology and the treatment of infectious diseases. Br J Pharmacol. 2024;181:917–37.

PubMed  Google Scholar 

Nie W, Zhang Y, Cheng J, Xiu Q. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS ONE. 2012;7:e47926.

PubMed  PubMed Central  Google Scholar 

Machado MG, Tavares LP, Souza GVS, Queiroz-Junior CM, Ascencao FR, Lopes ME, et al. The annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia. FASEB J. 2020;34:2749–64.

PubMed  Google Scholar 

Sousa LP, Pinho V, Teixeira MM. Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: what can the future offer to COVID-19? Br J Pharmacol. 2020;177:3898–904.

PubMed  PubMed Central  Google Scholar 

Rago F, Melo EM, Miller LM, Duray AM, Felix FB, Vago JP, et al. Treatment with lipoxin A 4 improves influenza A infection outcome through macrophage reprogramming, anti-inflammatory and pro-resolutive responses. Res Sq. 2024.

Tavares LP, Melo EM, Sousa LP, Teixeira MM. Pro-resolving therapies as potential adjunct treatment for infectious diseases: evidence from studies with annexin A1 and angiotensin-(1-7). Semin Immunol. 2022;59:101601.

PubMed  Google Scholar 

Magalhaes GS, Rodrigues-Machado MG, Motta-Santos D, Silva AR, Caliari MV, Prata LO, et al. Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br J Pharmacol. 2015;172:2330–42.

PubMed  PubMed Central  Google Scholar 

Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol. 2013;216:R1–17.

PubMed  Google Scholar 

Barroso LC, Silveira KD, Lima CX, Borges V, Bader M, Rachid M, et al. Renoprotective effects of AVE0991, a nonpeptide Mas receptor agonist, in experimental acute renal injury. Int J Hypertens. 2012;2012:808726. https://doi.org/10.1155/2012/808726.

Article  PubMed  PubMed Central  Google Scholar 

Silveira KD, Coelho FM, Vieira AT, Barroso LC, Queiroz-Junior CM, Costa VV, et al. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis. Peptides. 2013;46:53–63.

PubMed  Google Scholar 

da Silveira KD, Coelho FM, Vieira AT, Sachs D, Barroso LC, Costa VV, et al. Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol. 2010;185:5569–76.

PubMed  Google Scholar 

Rago F, Melo EM, Kraemer L, Galvao I, Cassali GD, Santos RAS, et al. Effect of preventive or therapeutic treatment with angiotensin 1–7 in a model of bleomycin-induced lung fibrosis in mice. J Leukoc Biol. 2019;106:677–86.

PubMed  Google Scholar 

Collins KL, Younis US, Tanyaratsrisakul S, Polt R, Hay M, Mansour HM, et al. Angiotensin-(1-7) peptide hormone reduces inflammation and pathogen burden during Mycoplasma pneumoniae infection in mice. Pharmaceutics. 2021. https://doi.org/10.3390/pharmaceutics13101614.

Article  PubMed  PubMed Central  Google Scholar 

Melo EM, Del Sarto J, Vago JP, Tavares LP, Rago F, Goncalves APF, et al. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection. Pharmacol Res. 2021;163:105292. https://doi.org/10.1016/j.phrs.2020.105292.

Article  PubMed  Google Scholar 

Zaidan I, Tavares LP, Sugimoto MA, Lima KM, Negreiros-Lima GL, Teixeira LC, et al. Angiotensin-(1-7)/MasR axis promotes migration of monocytes/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis. JCI Insight. 2022. https://doi.org/10.1172/jci.insight.147819.

Article  PubMed  PubMed Central  Google Scholar 

Machado MG, Patente TA, Rouille Y, Heumel S, Melo EM, Deruyter L, et al. Acetate improves the killing of Streptococcus pneumoniae by alveolar macrophages via NLRP3 inflammasome and glycolysis-HIF-1alpha axis. Front Immunol. 2022;13:773261.

PubMed  PubMed Central  Google Scholar 

Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990;3:171–96.

PubMed  PubMed Central  Google Scholar 

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.

PubMed  PubMed Central  Google Scholar 

Magalhaes GS, Barroso LC, Reis AC, Rodrigues-Machado MG, Gregorio JF, Motta-Santos D, et al. Angiotensin-(1-7) promotes resolution of eosinophilic inflammation in an experimental model of asthma. Front Immunol. 2018;9:58.

PubMed  PubMed Central  Google Scholar 

Barroso LC, Magalhaes GS, Galvao I, Reis AC, Souza DG, Sousa LP, et al. Angiotensin-(1-7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice. Front Immunol. 2017;8:1596.

PubMed  PubMed Central  Google Scholar 

Bastos AC, Magalhaes GS, Gregorio JF, Matos NA, Motta-Santos D, Bezerra FS, et al. Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase. Immunobiology. 2020;225:151893.

PubMed  Google Scholar 

Russo RC, Guabiraba R, Garcia CC, Barcelos LS, Roffe E, Souza AL, et al. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol. 2009;40:410–21.

PubMed  Google Scholar 

Marim FM, Silveira TN, Lima DS, Jr., Zamboni DS. A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PLoS One 2010; 5:e15263.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.

PubMed  Google Scholar 

Garcia CC, Russo RC, Guabiraba R, Fagundes CT, Polidoro RB, Tavares LP, et al. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. PLoS Pathog. 2010;6:e1001171.

PubMed  PubMed Central  Google Scholar 

Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Sci (Weinh). 2021;8:e2004433.

PubMed 

Comments (0)

No login
gif